News

Other Vascular Malformations – a brief overview

Published on: 08/03/2021

Other Vascular Malformations – a brief overview
Patients
Member News

This is the second article of the Dutch global non-profit patient organisation for patients with CMTC and Other Vascular (bloodvessel) Malformations, their families and healthcare providers.

In our body the blood flows through many thousands of kilometres of blood vessels.

Some blood vessels are very large and thick, such as the veins and the arteries. Some blood vessels are very thin, such as the capillaries.

Within dermatology, there are hundreds of diseases of the skin. Vascular anomalies are defects that are visible within the skin (sometimes you only see a swelling) by change of (blood) vessels. There are various types vascular abnormalities.

The vascular anomalies can be classified into two groups: the vascular malformations and vascular tumours. See the table below with examples.

There are multiple formats. Some people share the deviations, for example, by looking at the speed of the blood through the vessels: “high-flow” and “low-flow”. In the past, most vascular diseases referred to as ‘Hemangioma’. However, this is unwarranted, because different vascular disease ethology, course, or another treatment. Nowadays we talk, if we are talking about real Hemangiomas, rather about infantile hemangiomas (infantile hemangioma, IH).

Vascular abnormalities may not always cause problems but need to be checked. It is good to always good to have a “birth spot” or stain checked (we are not talking here about moles). We can distinguish the two groups, as said a group that is not causing problems (non-alarming) and a group that is causing problems (alarming).

In the case of vascular malformations, the family doctor will almost always refer you to a specialist such as (children’s) dermatologist or child surgeon for non-alarming abnormalities to get the correct diagnosis. For alarming defects you may be referred by the doctor to a special multidisciplinary team of specialists.

When treating hemangiomas there are many developments occurring in the treatment of these. Patients with non-alarming hemangiomas do not need to be redirected because they usually do not need to be treated. The GP will monitor these deviations. Should there be any cosmetic objections or doubts the GP may then refer the patient to the (children’s) dermatologist. For alarming hemangiomas the family doctor can refer you to a multidisciplinary team of specialists.

The next time we will discuss the psychological and psychosocial aspects of living with a rare disease (so disease independent).

For more information: www.cmtc.nl/en

NEWS​

Related News

Health innovators eye fast-track growth as Leeds transforms historic medical school

16 May 2025
Innovation in healthcare is switching to the fast lane in Leeds as partners shape a globally-leading approach to supporting businesses set to occupy t...

Global Cancer Ecosystem launched to tackle health inequalities worldwide

15 May 2025

BRAINTEASER Legacy: Data, tools and knowledge for advancing future research in digital health for Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS)

14 May 2025
BRAINTEASER Final event – Tuesday 3rd June 2025 – @ENCALS 2025 Meeting

ATRIDE Launches the Next-Gen “Holter for the Lungs” At Web Summit Vancouver 2025

14 May 2025
Atride lung shirt is part of the larger EU funded Digilung project lead by Tehnopol, partners Atride, MoveUP, Cognuse, VUB. The project is highly rele...

Open call of 40k for up to 6-Month VR/AR Co-Creation with Leading European SMEs

13 May 2025
The VR Health Champions project, coordinated by Instituto Pedro Nunes (IPN), has launched an Open Call offering up to €40,000 to SMEs developing innov...

Toronto’s new innovation studio highlights aging-in-place solutions

13 May 2025
Located in the heart of downtown Toronto, the AGE-WELL Innovation Studio is your gateway to the future of aging and care. Whether you’re a tech compan...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *